Site Search

 

 

 

 

 

Home
General Topics
       Residual Renal Function
          The Importance of RRF
          Contrast Media
       Diabetes Management
          General Facts
          Pathophysiology
          PD and the Diabetic Patient
       Renal Osteodystrophy
          Renal Osteodystrophy Clinical Studies
       Numbers-Their Use and Interpretation
       Basic Statistics
       Choices for Home Dialysis
       Other
          Vaccinating CKD and Dialysis Patients
          32 yr dialysis patient receives Achievement award
Peritoneal Dialysis
       History of PD
          PD - The Foundations
          Early Clinical Experiences with PD
       Kinetic Principles
          Basic Principles of PD
             What is Dialysis?
             Anatomy of the Peritoneum
             Physiology of the Peritoneum
          StdKt/V - Dose Equivalency
       Peritoneal Transport 
          Understanding Testing Methods
          Prognostic Value of Transport Status
          Peritoneal Function After Exposure to PD
       Modalities of Therapy
          PD Techniques
          PD Modalities
       PD Adequacy
          Prescribing Dialysis
             Targets of PD Prescription
             Determinants of Dose
             Exchange Volume and Position
             How to Reach the Goals
             Monitoring the PD Patient
             Evaluating the Patient as a Whole
             Response to Inadequate Peritoneal Dialysis
          Difficulties in Providing Adequate Dialysis
       Ultrafiltration
          Importance of Volume Control
          How to Achieve Adequate PD UF
       Clinical Procedures
       Complications
          Non-Infectious Complications of PD
          Peritoneal Dialysis-Related Infections
             Peritonitis
             Management of ESI
       Dialysis Access
          The Evolution of PD Catheters
          Preop Management
          Placement of PD Catheters
          Intraoperative Management
          Post Operative Care and Management
          Complications of PD Catheters
       Clinical Outcomes
          Clinical outcomes of PD and HD
       Peritoneal Dialysis in Children
          Pediatric ESRD Incidence, Prevalence and Mortality
          Management of the pediatric patient on PD
          Utilization of PD for Acute Renal Failure and ESRD
          Prescription principles, adequacy and PET
          Additional care considerations: Nutrition, Growth,
       Dialysis Equipment & Disposables
          PD Solutions
       PD in the ICU
       Home Program Management
Hemodialysis
       History of Hemodialysis
       Kinetic Principles
          Impact of t & Kr on Kt/V
          StdKt/V - Dose Equivalency
       Modalities of Therapy
          Hemodialysis Regimens/Prescriptions
          Extracorporeal Modalities
       Home HD
          Introduction
          HD Regimens/Prescriptions
          The Influence of Dose, Time & Frequency
          Every other day HD (HD3.5)
          Time Versus Dialysis-Free Interval
          Benefits of Increased HD Frequency
          Increased Frequency – Other Modalities
          Potential Lifestyle Benefits of HD3.5
          Home Program Management
             Establishing a Home Program
       Intradialytic Complications
       Adequacy
          Difficulties in Prescribing Adequate Dialysis
       Sodium Modeling
       Hemodialysis Access
          Introduction to Vascular Access
          Overview of Arteriovenous Fistula
          Overview of Arteriovenous Grafts
          Overview of Central Venous Catheters
          Vascular Access Monitoring and Surveillance
       Access Complications
          Overview of Hemodialysis Complications
          AVF Stenosis
          Interventions for AVF and AVG Stenosis
          Primary Fistula Failure
          Catheter Related Bacteremia
Sorbent Technology
       History of Sorbent Technology
Seminars & Education
       WebEx Physician Courses
       WebEx Teleconference Workshops
       Online Nursing Courses
Educational Initiatives
Training Resources
       Kidney Options Kidney Options
       Patient Training Resources
       Training Resources for Professionals Training Resources for Professionals
Product Information
       Peritoneal Dialysis
          Fresenius Peritoneal Dialysis Connections
       Hemodialysis
Glossary
Links
       Journals
       Organizations
       Other Links
Contact Information
Calendar of Events
Contributors

Every other day HD (HD3.5)

 

Before embracing HD3.5 as the preferred prescription, we must rigorously evaluate its domain of adequacy, its effective cost in light of current reimbursement and its influence on patient lifestyles.  In 1998, Mastrangelo reported the findings of a program of dialysis targeting reduction of the long interdialytic interval while maintaining conventional-short dialysis time (£ 4 hours) by use of high blood flow rates and efficient dialyzers with bicarbonate dialysate1.  Enrollment in this study started in 1978 and by 1993 224 patients had been recruited.  Dialysis prescription was alternate daily (7 sessions per two weeks) for smaller patients and 4-times weekly for larger patients.  Dialysis session times of less than 180 minutes were prescribed but subsequently were abandoned.  Average spKt/V was 1.31.  No dietary restrictions were advised.  Interdialytic weight gains were in the range 2.6 to 2.9 kg, strongly suggesting that sodium intake was not restricted.  Blood pressure was deemed controlled in 85% of patients with only 39% of patients requiring antihypertensive medications. Anemia was reasonably managed (average hematocrit 31%) without erythropoietin.  Nutrition (nPCR and serum albumin) was adequate. Sixty-nine patients (31%) died over a period of 17 years (1978-1994) and probability of survival at 10 years was 60%.  Comparing the results for the Lecce program and that for the Tassin patients, incident from 1975–1979 (168 patients) and from 1984-1989 (239 patients), yields the data shown below.

 

06 Lecce tassin survival sm.gif

Survival curves replotted for the Lecce patients and two cohorts from the Tassin experience

Click image to enlarge

 

By this comparison, patient survival in the Lecce program exceeds that in Tassin in the 1985-1989 cohort and is equivalent to that in 1975-1979 cohort.  Patients in Tassin dialyzed 24 hours per week and had a long interdialytic interval of 64 hours.  Patients in Lecce dialyzed between 10.5 and 12 hours per week but had a long interdialytic interval of only 45 hours.

 

Domain of adequacy of HD3.5

 

Next

 

Reference:

  1. Mastrangelo F, Alfonso L, Napoli M, DeBlasi V, Russo F, Patruno P. Dialysis with increased frequency of sessions (Lecce dialysis). Nephrol Dial Transplant 13 (Suppl 6):139-147, 1998
Print  
© 2006-2010, Fresenius Medical Care North America. All Rights Reserved. | Terms Of Use | Privacy Statement | Register | Login